Advertisement
Advertisement

BLTE

BLTE logo

Belite Bio, Inc - ADR

148.89
USD
Sponsored
-4.35
-2.84%
Jul 10, 14:49 UTC -4
Open

BLTE Earnings Reports

Positive Surprise Ratio

BLTE beat 5 of 15 last estimates.

33%

Next Report

Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$0.80
Implied change from Q1 26 (Revenue/ EPS)
--
/
+17.65%
Implied change from Q2 25 (Revenue/ EPS)
--
/
+60.00%

Belite Bio, Inc - ADR earnings per share and revenue

On May 20, 2026, BLTE reported earnings of -0.68 USD per share (EPS) for Q1 26, missing the estimate of -0.64 USD, resulting in a -4.87% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +2.62% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of -0.80 USD, with revenue projected to reach -- USD, implying an increase of 17.65% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Replimune Group, Inc.
Report Date
Jun 29, 2026 For Q4 26
Estimate
-$0.72
Actual
-$0.76
Surprise
-4.52%
logo
Beyond Air, Inc. Common Stock
Report Date
Jun 26, 2026 For Q4 26
Estimate
-$0.57
Actual
-$0.63
Surprise
-9.00%
FAQ
For Q1 2026, Belite Bio, Inc - ADR reported EPS of -$0.68, missing estimates by -4.87%, and revenue of $0.00, 0% as expectations.
The stock price moved up 2.62%, changed from $139.70 before the earnings release to $143.36 the day after.
The next earning report is scheduled for Aug 10, 2026.
Based on -- analysts, Belite Bio, Inc - ADR is expected to report EPS of -$0.80 and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement